Next Article in Journal
Preclinical Absorption, Distribution, Metabolism, and Excretion of an Oral Amide Prodrug of Gemcitabine Designed to Deliver Prolonged Systemic Exposure
Next Article in Special Issue
Delivery of Cancer Therapeutics Using Nanotechnology
Previous Article in Journal
Design, Synthesis and in Vitro Degradation of a Novel Co-Drug for the Treatment of Psoriasis
Previous Article in Special Issue
From Molecular to Nanotechnology Strategies for Delivery of Neurotrophins: Emphasis on Brain-Derived Neurotrophic Factor (BDNF)
Pharmaceutics 2013, 5(2), 246-260; doi:10.3390/pharmaceutics5020246

Notes on Article Versions

NoteDate
Article Published23 April 2013 11:48 CEST
article pdf uploaded.23 April 2013 11:49 CEST
article word file uploaded.23 April 2013 11:49 CEST
abstract image uploaded.23 April 2013 11:49 CEST
article files uploaded.23 April 2013 11:49 CEST
article files uploaded.23 April 2013 11:49 CEST
article files uploaded.23 April 2013 11:49 CEST
article files uploaded.23 April 2013 11:49 CEST
article files uploaded.23 April 2013 11:49 CEST
article files uploaded.23 April 2013 11:49 CEST
article files uploaded.23 April 2013 11:49 CEST
Pharmaceutics EISSN 1999-4923 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert